youtube_live
Q3 2026 earnings • 8:30 AM tomorrow
See detailschevron_right
AMRX:NASDAQ
Amneal Pharmaceuticals Inc
$20.44
arrow_downward
-4.97%(-1.07) 1D
$20.23
arrow_downward
-1.05% (-0.21)bedtimeAfter hours
Closed: Nov 2, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMRX...
Open
$21.53
High
$21.68
Low
$20.30
Mkt. cap
7.12B
Avg. vol.
3.80M
Volume
5.02M
P/E ratio
42.65
52-wk high
$21.68
52-wk low
$10.68
EPS
$0.48
Beta
1.22
Shares outstanding
348.30M
No. of employees
9K
Open
$21.53
High
$21.68
Low
$20.30
Mkt. cap
7.12B
Avg. vol.
3.80M
Volume
5.02M
P/E ratio
42.65
52-wk high
$21.68
52-wk low
$10.68
EPS
$0.48
Beta
1.22
Shares outstanding
348.30M
No. of employees
9K
News stories
From web sources and news partners
Zacks
·
11 hours ago
Iovance Gears Up to Report Q3 Earnings: Here's What to Expect
Zacks
·
11 hours ago
ETON Gears Up to Report Q3 Earnings: What Can Investors Expect?
Zacks
·
13 hours ago
Precigen Gears Up to Report Q3 Earnings: What Can Investors Expect?
Investing.com
·
13 hours ago
Amneal earnings on deck: Can biosimilars offset margin pressure?
Profile
Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products. The company is headquartered in Bridgewater, New Jersey, and is one of the largest manufacturers of generic drugs in the United States. Wikipedia
About Amneal Pharmaceuticals Inc
CEOChintu Patel | Chirag Patel
Employees8.7K
Founded2002
HeadquartersBridgewater, New Jersey, United States
SectorPharmaceutical industry
Websiteamneal.com